REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Detrapharm Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Dog and Cat Food Manufacturing | Coffee and Tea Manufacturing | All Other Food Manufacturing | All Other Miscellaneous Food Manufacturing | Soft Drink Manufacturing | Toilet Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Packaging and Labeling Services
Full name: Detrapharm Sp. z o.o. Profile Updated: June 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Detrapharm Sp. z o.o. is a company in Poland, with a head office in Krakow. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on September 21, 2017. From the latest financial highlights, Detrapharm Sp. z o.o. reported a net sales revenue increase of 23.34% in 2022. Its total assets grew by 46.3% over the same period. In, 2022, the company’s net profit margin increased by 12.13%.

Headquarters
Ul. Zygmunta Radnickiego 11
Krakow; Malopolskie; Postal Code: 30-498

Contact Details: Purchase the Detrapharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Detrapharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Detrapharm Sp. z o.o. report to view the information.
Incorporation Date:
September 21, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Smart Biotics Sp. z o.o.
60%
Company Performance
Financial values in the chart are available after Detrapharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.34%▲
Total operating revenue
45.07%▲
Operating profit (EBIT)
393.05%▲
Net Profit (Loss) for the Period
345.81%▲
Total assets
46.3%▲
Total equity
N/A
Operating Profit Margin (ROS)
13.9%▲
Net Profit Margin
12.13%▲
Return on Equity (ROE)
N/A

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Blakpol Sp. z o.o.
 
Pharmanta-Europe Sp. z o.o.
Human Biome Institute S.A.
 
Symbio-Lab Sp. z o.o.
Life Solutions Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo